Back

Nuclear receptor LRH-1 regulates early T cell development in mice

Brunner, T.; Wiedmann, A.; Käter, N.; Elshikhidriss, R. H.; Dietrich, L.; Merk, V. M.; Rudolf, F.; Legler, D. F.

2026-05-14 immunology
10.64898/2026.05.11.724315 bioRxiv
Show abstract

T cell development in the thymus requires tightly coordinated transcriptional programs that regulate lineage commitment, proliferation and differentiation. While key transcription factors controlling these processes have been extensively characterized, the contribution of the low expressed nuclear receptor Liver Receptor Homolog 1 (LRH-1, Nr5a2) in T cell development remains unexplored. Here, we investigated the role of LRH-1 in thymocyte maturation using an inducible ex vivo deletion system and in vivo Lck-Cre- and CD4-Cre-mediated LRH-1 knockout mouse models. We demonstrate that inducible LRH-1 deletion impairs early thymocyte development, identifying LRH-1 as a critical regulator of the double negative (DN)2/DN3 to DN4 transition. Early Lck-Cre-mediated deletion of LRH-1, but not CD4-Cre-mediated deletion at the double positive stage, resulted in markedly reduced thymic size and cellularity, indicating a stage-specific requirement for LRH-1 during thymopoiesis. Lck-Cre-mediated LRH-1 deletion led to a decreased frequency of mature CD4 T cells in peripheral lymphoid organs, while the remaining mature T cells were predominantly Cre reporter-negative and therefore escaped LRH-1 deletion. CD4 T cells that escaped Cre-mediated LRH-1 deletion exhibited impaired T cell activation marker expression and cytokine secretion. In vivo, these defects resulted in attenuated T cell effector function and compromised regulatory T cell-mediated protection in a T cell transfer model of colitis, indicating impaired effector and regulatory T cell function under (patho)physiological conditions. Collectively, our findings identify LRH-1 as a critical, previously unrecognized regulator of early thymocyte development, and establish its essential role in shaping functional peripheral CD4 T cell-mediated immune responses.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
The Journal of Immunology
146 papers in training set
Top 0.1%
14.3%
2
JCI Insight
241 papers in training set
Top 0.2%
10.1%
3
eLife
5422 papers in training set
Top 6%
10.1%
4
Mucosal Immunology
42 papers in training set
Top 0.1%
4.8%
5
Cell Reports
1338 papers in training set
Top 10%
4.8%
6
Frontiers in Immunology
586 papers in training set
Top 2%
4.8%
7
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 18%
3.9%
50% of probability mass above
8
Journal of Experimental Medicine
106 papers in training set
Top 0.9%
3.7%
9
Journal of Clinical Investigation
164 papers in training set
Top 1%
3.1%
10
Immunity
58 papers in training set
Top 2%
2.7%
11
Science Immunology
81 papers in training set
Top 0.7%
2.7%
12
PLOS Pathogens
721 papers in training set
Top 5%
1.9%
13
Nature Communications
4913 papers in training set
Top 49%
1.9%
14
Scientific Reports
3102 papers in training set
Top 55%
1.8%
15
Science Signaling
55 papers in training set
Top 0.1%
1.7%
16
PLOS ONE
4510 papers in training set
Top 58%
1.3%
17
ImmunoHorizons
21 papers in training set
Top 0.1%
1.3%
18
PLOS Genetics
756 papers in training set
Top 10%
1.3%
19
European Journal of Immunology
57 papers in training set
Top 0.3%
1.3%
20
Cellular & Molecular Immunology
14 papers in training set
Top 1%
1.2%
21
PLOS Biology
408 papers in training set
Top 14%
1.2%
22
iScience
1063 papers in training set
Top 22%
1.2%
23
Gastroenterology
40 papers in training set
Top 1%
1.1%
24
Immunology
29 papers in training set
Top 0.7%
1.1%
25
Nature Immunology
71 papers in training set
Top 2%
0.7%
26
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
27
EMBO reports
136 papers in training set
Top 8%
0.6%